ABSTRACT
BACKGROUND: Despite widespread use of electronic data capture (EDC) systems for research and electronic health records (EHR), most transfer of data between EHR and EDC systems is manual and error prone. Increased adoption of Health Level Seven Fast Healthcare Interoperability Resource (FHIR) application programming interfaces (APIs) in recent years by EHR systems has increased the availability of patient data for external applications such as REDCap. OBJECTIVE: Describe the development of the REDCap Clinical Data Interoperability Services (CDIS) module that provides seamless data exchange between the REDCap research EDC and any EHR system with a FHIR API. CDIS enables end users to independently set up their data collection projects, map EHR data to fields, and adjudicate data transfer without project-by-project involvement from Health Information Technology staff. METHODS: We identified two use cases for EHR data transfer into REDCap. Clinical Data Pull (CDP) automatically pulls EHR data into user-defined REDCap fields and replaces the workflow of having to transcribe or copy and paste data from the EHR. Clinical Data Mart (CDM) collects all specified data for a patient over a given time period and replaces the process of importing EHR data for registries from research databases. With an iterative process, we designed our access control, authentication, variable selection, and mapping interfaces in such a way that end users could easily set up and use CDIS. RESULTS: Since its release, the REDCap CDIS has been used to pull over 19.5 million data points for 82 projects at Vanderbilt University Medical Center. Software and documentation are available through the REDCap Consortium. CONCLUSIONS: The new REDCap Clinical Data and Interoperability Services (CDIS) module leverages the FHIR standard to enable real-time and direct data extraction from the EHR. Researchers can self-service the mapping and adjudication of EHR data into REDCap. The uptake of CDIS at VUMC and other REDCap consortium sites is improving the accuracy and efficiency of EHR data collection by reducing the need for manual transcription and flat file uploads.
Subject(s)
Electronic Health Records , Health Level Seven , Data Warehousing , Delivery of Health Care , Humans , WorkflowABSTRACT
BACKGROUND: Tuberculosis (TB) diagnosis in human immunodeficiency virus (HIV) positive persons is difficult, particularly in resource-limited settings. The relationship between TB culture status and mortality in HIV-positive persons treated for TB is unclear. METHODS: We evaluated HIV-positive adults treated for TB at or after their first HIV clinic visit in Argentina, Brazil, Chile, Honduras, Mexico or Peru from 2000 to 2015. Anti-tuberculosis treatment included 2 months of isoniazid, rifampicin (RMP)/rifabutin (RBT), pyrazinamide ± ethambutol, followed by continuation phase treatment with isoniazid + RMP/RBT. RESULTS: Of 759 TB-HIV patients, 238 (31%) were culture-negative, 228 (30%) had unknown culture status or did not undergo culture and 293 (39%) were culture-positive. The median CD4 at TB diagnosis was 96 (interquartile range 40-228); 636 (84%) received concurrent antiretroviral therapy (ART) and anti-tuberculosis treatment. There were 123 (16%) deaths: 90/466 (19%) with TB culture-negative, unknown or not performed vs. 33/293 (11%) who were TB culture-positive (P = 0.005). In Kaplan-Meier analysis, mortality in TB patients without culture-confirmed disease was higher (P = 0.002). In a Cox model adjusted for age, sex, CD4, ART timing, disease site and stratified by study site, mortality in persons without culture-confirmed TB was not significantly increased compared to those with culture-positive TB (hazard ratio 1.39, 95%CI 0.89-2.16, P = 0.15). CONCLUSION: Most HIV-positive patients treated for TB did not have culture-confirmed TB, and mortality tended to be higher in patients without culture-confirmed disease, although the association was not statistically different after adjusting for other variables. Accurate TB diagnosis in HIV-positive persons is crucial.
Subject(s)
Anti-HIV Agents/administration & dosage , Antitubercular Agents/administration & dosage , HIV Infections/complications , Tuberculosis/diagnosis , Adult , CD4 Lymphocyte Count , Female , HIV Infections/drug therapy , HIV Infections/mortality , Humans , Latin America , Male , Tuberculosis/drug therapyABSTRACT
OBJECTIVE/BACKGROUND: The objective was to compare 2 year outcomes in patients treated with or without predilatation prior to drug coated balloon (DCB) angioplasty for symptomatic femoropopliteal lesions. METHODS: This prospective multicentre pilot study was conducted at three sites in Germany. It compared claudicants undergoing predilatation with a bare percutaneous transluminal angioplasty (PTA) balloon before DCB (predilatation group) with patients undergoing direct DCB (direct DCB group). Patients were followed for 2 years. Outcomes included late lumen loss at 6 months, and ankle brachial index (ABI), major adverse events, and primary patency at 2 years. A Clinical Events Committee and core laboratories analysed adverse events and angiographic/duplex images, respectively. RESULTS: Between December 2011 and November 2012, 50 patients were enrolled to the predilatation group (12% total occlusions) and 28 to the direct DCB group (5% total occlusions). Follow-up compliance at the 2 year visit was 88% (n = 44) and 86% (n = 24), respectively. Late lumen loss at 6 months was lower in the direct DCB group (0.03 ± 0.68 mm vs. 0.54 ± 0.97 mm; p = .01). Major adverse events over 2 years occurred in seven (15%) patients who underwent predilatation and in five (19%) after direct DCB. Mean ABI at 2 years was 0.94 ± 0.15 after predilatation and 1.0 ± 0.12 after direct DCB. Over 2 years, primary patency (80.3% vs. 78.2%; p = .55) was not statistically different between the groups. After propensity score adjustments, 2 year findings remained unchanged. CONCLUSION: Paclitaxel coated PTA, with or without bare predilatation, is effective over 2 years in symptomatic patients with femoropopliteal stenotic lesions. Adequately powered randomised controlled comparisons are required to confirm these preliminary results.
Subject(s)
Angioplasty, Balloon/instrumentation , Cardiovascular Agents/administration & dosage , Coated Materials, Biocompatible , Femoral Artery , Paclitaxel/administration & dosage , Peripheral Arterial Disease/therapy , Popliteal Artery , Vascular Access Devices , Aged , Angioplasty, Balloon/adverse effects , Ankle Brachial Index , Cardiovascular Agents/adverse effects , Chi-Square Distribution , Constriction, Pathologic , Female , Femoral Artery/diagnostic imaging , Femoral Artery/physiopathology , Germany , Humans , Kaplan-Meier Estimate , Logistic Models , Male , Middle Aged , Paclitaxel/adverse effects , Peripheral Arterial Disease/diagnosis , Peripheral Arterial Disease/physiopathology , Pilot Projects , Popliteal Artery/diagnostic imaging , Popliteal Artery/physiopathology , Propensity Score , Proportional Hazards Models , Prospective Studies , Prosthesis Design , Time Factors , Treatment Outcome , Vascular PatencyABSTRACT
A large clinical care and research organization in Haiti required an electronic medical record system (EMR) to serve the needs of its 30 interlinked clinical programs. After assessing available open source software, the local team designed and implemented a modular proprietary EMR that is improving data quality and patient care. Despite the many benefits of existing open source medical record systems, clinical centers with complex workflow patterns--even those in resource-limited settings--should consider developing sustainable, local systems that fit their care model.
Subject(s)
Clinical Laboratory Information Systems/organization & administration , Delivery of Health Care, Integrated/organization & administration , Electronic Health Records/organization & administration , HIV Infections/therapy , Medical Record Linkage/methods , Point-of-Care Testing/organization & administration , HIV Infections/diagnosis , Haiti , Humans , Medical Order Entry Systems/organization & administration , Models, Organizational , User-Computer InterfaceABSTRACT
BACKGROUND: In cases of distal radius fractures information about the regional distribution of cancellous bone is essential for adequate fixation of osteosynthesis material. MATERIALS AND METHODS: Using quantitative computed tomography (qCT) measurements 12 distal radii were divided into 2 groups (good and bad bone quality). High-resolution CT scans were obtained at 13 locations (1-40 mm distant from radial styloid processes). The resulting cross-sections were divided into 4 quadrants and the cancellous bone density was assessed in each of them. RESULTS: In both groups regional cancellous bone density was highest immediately beneath the joint surface and decreased towards the metaphyseal region. Comparing the radial with the ulnar quadrants significant differences were found between distances of 4 mm and 12 mm from the joint surface in both groups. The comparison of the palmar and the dorsal quadrants resulted in an almost identical cancellous bone distribution. CONCLUSION: In osteoporotic distal radii cancellous bone density decrease occurs homogeneously in all regions and is least pronounced beneath the joint surface. Comparing the regional cancellous bone density (radial versus ulnar and palmar versus dorsal) significant differences were mainly found near the joint surface in both groups.
Subject(s)
Osteoporosis/diagnostic imaging , Radius/diagnostic imaging , Tomography, X-Ray Computed , Aged, 80 and over , Female , Humans , Male , Middle Aged , Reproducibility of Results , Sensitivity and SpecificityABSTRACT
PURPOSE: To evaluate CT-guided radiofrequency (RF) ablation of osteoid osteoma using internally cooled monopolar RF electrodes for technical success, complications and clinical long-term success. MATERIALS AND METHODS: Between April 1999 and July 2006, 23 patients were treated under general anesthesia with CT-guided RF ablation using an internally cooled monopolar single RF electrode (Cool-tip, Valleylab, TycoHealthcare, Boulder, USA; active tip: 10 mm). For the removal of the nidus, we used either a manual or an automated drill. The technical success was evaluated by a CT scan (MSCT, Siemens Medical Solutions, Forchheim). The clinical long-term success was investigated by questioning patients prior to discharge, and after 6, 12 and 18 months. After 18 months, patients were interviewed on an annual basis. RESULTS: The technical success rate was 100 %. The nidus was located in n = 19 cases at the lower extremity and in n = 4 cases at the upper extremity. Minor complications were observed for n = 2 patients. The mean hospitalization time was 1.5 d (1-2 d). The mean follow-up was 75.9 months (18-120 months) for n = 23 patients. No local recurrence was observed. One patient had intermediate pain one week after RF ablation without recurrent symptoms. CONCLUSION: CT-guided RF ablation using an internally cooled monopolar single RF electrode is an effective and safe minimally invasive method for the treatment of osteoid osteoma with excellent clinical long-term success.
Subject(s)
Bone Neoplasms/surgery , Catheter Ablation/methods , Minimally Invasive Surgical Procedures/methods , Osteoma, Osteoid/surgery , Surgery, Computer-Assisted/methods , Tomography, X-Ray Computed/methods , Adolescent , Adult , Bone Neoplasms/diagnostic imaging , Bone Neoplasms/pathology , Catheter Ablation/instrumentation , Equipment Failure , Female , Follow-Up Studies , Humans , Length of Stay , Male , Middle Aged , Osteoma, Osteoid/diagnostic imaging , Osteoma, Osteoid/pathology , Postoperative Complications/etiology , Surgery, Computer-Assisted/instrumentation , Surgical Instruments , Tomography, X-Ray Computed/instrumentation , Treatment Outcome , Young AdultABSTRACT
BACKGROUND: Phytoestrogens are naturally occurring, plant-derived, nonsteroidal phytochemicals with anticarcinogenic potential. The aim of this study was to isolate phytoestrogens from the flax root of Linum usitatissimum and to test their effect on cellular metabolism in the human mammalian carcinoma cell line MCF-7 using the Bionas 2500 analysis system. MATERIALS AND METHODS: Metabolically relevant parameters such as acidification, oxygen consumption and cell adhesion were registered continuously over 8 and 24 hours on six sensor chips in parallel at different concentrations of flax root extracts. RESULTS: The extracts from flax roots of L. usitatissimum reduced extracellular acidification, respiration and adhesion in a concentration-dependent manner. CONCLUSION: The Bionas 2500 analysis system allows multiparametric online monitoring of cellular processes and can be used to detect the mode of action of anticarcinogenic compounds in cellular metabolism.
Subject(s)
Computational Biology/methods , Flax/metabolism , Gene Expression Regulation , Oligonucleotide Array Sequence Analysis/methods , Phytoestrogens/metabolism , Plant Extracts/metabolism , Biosensing Techniques , Cell Adhesion , Cell Line, Tumor , Equipment Design , Humans , Metabolism , Oxygen Consumption , Tetrazolium Salts/pharmacology , Thiazoles/pharmacology , Time FactorsABSTRACT
Metastases from uveal melanoma are often confined to the liver. Palliative hepatic chemoembolization has been considered to be a reasonable treatment approach. We enrolled 14 patients with hepatic metastases from uveal melanoma into a pilot trial of transarterial chemoembolization (TACE). All patients received additional systemic immuno-chemotherapy or best supportive care. In 31 procedures 100mg/m(2) of cisplatine was continuously infused by means of a power injector preceding embolization by manual injection of polyvinyl alcohol particles. In three procedures cisplatine was replaced by 200mg/m(2) carboplatine because of increased serum creatinine levels. Tumor response was evaluated using RECIST criteria. Fourteen patients received 34 TACE's (mean: 2.4 treatments). Eight patients (57%) achieved partial response (PR), four patients (29%) had stable disease and two patients (14%) tumor progression. Median time to progression was 8.5 months (5-35 months). Median survival after first TACE was 14.5 months in responders compared to 10 months in non-responders (p=0.18, not significant) and 11.5 months (3-69 months) in all patients. In seven patients with metastases occupying less than 25% of liver volume median survival was 17 months compared to 11 months in seven patients with tumor involvement of more than 25% (p=0.02) with partial response rate of 86% and 29%, respectively. TACE of liver metastases from uveal melanoma is well tolerated and may prolong survival in patients with limited tumor extension.
Subject(s)
Embolization, Therapeutic/methods , Liver Neoplasms/diagnosis , Liver Neoplasms/secondary , Melanoma/drug therapy , Melanoma/secondary , Polyvinyl Alcohol/therapeutic use , Uveal Neoplasms/drug therapy , Female , Hemostatics/therapeutic use , Humans , Liver Neoplasms/drug therapy , Male , Melanoma/diagnosis , Pilot Projects , Treatment Outcome , Uveal Neoplasms/diagnosisABSTRACT
Carotid endarterectomy has demonstrated its superiority over medical treatment of symptomatic as well as asymptomatic stenosis of the extracranial carotid artery. Although minimally invasive methods initially failed to produce similar results, stent implantation is becoming an alternative technique for stroke prophylaxis with technical advances, cerebral protection and careful patient selection. Even though restenosis does not seem to be a major limitation compared to coronary interventions, in-stent restenosis might occur more frequently with an increasing number of procedures performed and longer follow-up periods. Drug eluting stents have shown to attenuate this complication. Currently, no clinical data on drug eluting stents in carotid arteries are available. This article discusses the current literature on carotid artery stenting and the potential role of drug eluting stents in this field.
Subject(s)
Blood Vessel Prosthesis Implantation/instrumentation , Carotid Stenosis/surgery , Coated Materials, Biocompatible , Paclitaxel/therapeutic use , Sirolimus/therapeutic use , Stents , Stroke/prevention & control , Antineoplastic Agents, Phytogenic/therapeutic use , Humans , Immunosuppressive Agents/therapeutic use , Prosthesis Design , Secondary Prevention , Treatment OutcomeABSTRACT
PURPOSE: To evaluate the effect of dexamethasone on the growth of cultured human aortic smooth muscle cells in an in-vitro model depending on the dose applied. MATERIALS AND METHODS: Commercially available human aortic smooth muscle cells (haSMC) were incubated with different doses of dexamethasone (10(-6), 10(-8), 10(-10) mol/l). For 20 days, the dose-depending effects of dexamethasone on cell growth were studied by analyzing cell proliferation, clonogenic activity as well as cell cycle distribution. In addition, the migratory ability of haSMC was evaluated using a two compartment in-vitro model. RESULTS: Cell growth was reduced in a dose dependent manner. An applied dose of 10(-6) M dexamethasone effectively inhibited cell growth for the follow-up period of 20 days. Cell cycle analysis revealed a G1-phase block which was dose dependent and significant for a dose of 10(-6) M. Also a reduction of haSMC clonogenic activity could be found in the colony formation assays. Finally, dexamethasone reduced the migratory ability of the treated cells significantly for doses of 10(-6) and 10(-8) M. CONCLUSION: Depending on the dose applied, incubation with dexamethasone results in a significant growth reduction of cultured haSMC, which may be due to a drug induced G1-phase block. Dexamethasone also reduces the clonogenic activity as well as the migratory ability of cultured haSMC.
Subject(s)
Angioplasty, Balloon , Anti-Inflammatory Agents/pharmacology , Aorta/drug effects , Constriction, Pathologic/prevention & control , Dexamethasone/pharmacology , Muscle, Smooth, Vascular/cytology , Muscle, Smooth, Vascular/drug effects , Stents , Anti-Inflammatory Agents/administration & dosage , Aorta/cytology , Arteriosclerosis/prevention & control , Cell Cycle , Cell Movement/drug effects , Cells, Cultured , Colony-Forming Units Assay , Culture Media , Dexamethasone/administration & dosage , Follow-Up Studies , Graft Occlusion, Vascular , Humans , Hyperplasia , Recurrence , Time Factors , Tunica Intima/pathologyABSTRACT
A 12-year-old boy with Lennox syndrome presented with an acute abdomen and a history of progressive abdominal pain and vomiting over 3 weeks. The uncommon finding in this case was a foreign body detected in a lower loop of the jejunum causing radiological and clinical signs of jejunitis/ileitis. The foreign body had to be removed surgically and turned out to be a hard (originally soft) plastic part of a towel rack.
Subject(s)
Foreign Bodies/complications , Ileitis/etiology , Intestinal Obstruction/etiology , Abdominal Pain/etiology , Child , Humans , Ileitis/surgery , Intestinal Obstruction/surgery , Jejunum/diagnostic imaging , Jejunum/pathology , Jejunum/surgery , Male , Radiography , Treatment Outcome , Vomiting/etiologyABSTRACT
BACKGROUND: Hydration is a commonly used method to prevent the decline in GFR after contrast media (CM) application. So far, there have been no controlled, randomized trials investigating the most effective route of fluid administration. METHODS: Thirty-nine patients with normal renal function (65 +/- 9 years, serum creatinine 0.9 +/- 0.2 mg/dl, GFR = 110 +/- 31 ml/min/1.73 m2) receiving at least 80 ml of low-osmolality CM during an angiographic procedure were randomized to one of the following hydration regimens: Group 1: volume expansion with 300 ml saline during CM administration (n = 20, serum creatinine 0.8 +/- 0.1 mg/dl, GFR 119 +/- 27 ml/min/1.73 m2); Group 2: intravenous administration of at least 2,000 ml saline within 12 h before and after CM application (n = 19, serum creatinine 0.9 +/- 0.2 mg/dl, GFR 101 +/- 32 ml/min/1.73 m2). GFR was measured by CM clearance (Renalyzer) at baseline and 48 hours after CM administration. The primary end point was the mean change in the GFR after 48 hours, the secondary one was the incidence of CM-induced nephropathy (CMIN), defined as a decrease in GFR of more than 50% from the baseline GFR within 48 hours. RESULTS: Patients of group 1 showed a significantly (p < 0.05) higher decline in GFR (delta GFR 34.6 +/- 25.7 ml/min/1.73 m2) compared to patients receiving the intravenous prehydration regimen (delta GFR 18.3 +/- 25.0 ml/min/1.73 m2). The incidence of CMIN was lower in prehydrated patients (5.3%) compared to the other group (15%). CONCLUSION: In patients with normal renal function, intravenous prehydration seems to be a very effective and feasible method to prevent the decline in GFR after contrast media exposure. Volume expansion given only during the CM exposure appears not to be sufficient enough to prevent renal damage.
Subject(s)
Contrast Media/adverse effects , Fluid Therapy/methods , Kidney Diseases/chemically induced , Kidney Diseases/prevention & control , Aged , Contrast Media/pharmacokinetics , Creatinine/blood , Female , Humans , Male , Middle Aged , Prospective Studies , Statistics, NonparametricABSTRACT
PURPOSE: To determine independent prognostic factors influencing the survival of patients with hepatocellular carcinoma (HCC) treated with transcatheter arterial chemoembolization (TACE). MATERIALS AND METHODS: Ninety-one patients with unresectable HCC were treated with 269 repetitive TACE. The dosages of epirubicin (40-60 mg) and ethiodized oil (8-20 ml) were adjusted to tumor size and liver function. The impact of tumor size, macroscopic tumor type, tumor location, portal vein infiltration, capsular infiltration, tumor vascularization, uptake of ethiodized oil within the tumors, Child-Pugh-Class and Okuda-Stage on patient survival were evaluated by means of univariate and multivariate regression analysis. RESULTS: The following independent prognostic factors were found: tumor type (nodular vs. infiltrating, p = 0 008), tumor size (p = 0.01), Child-Pugh-Class (A vs. B; p = 0.02) and grade of tumor vascularization (p = 0.04). In 57 patients with HCC of the nodular type, the median survival time was significant longer than in 32 patients with HCC of the infiltrating type (17.0 months vs. 7.9 months; p < 0.003; 2 tumors could not be classified). The 1-, 2- and 3-year-survival rates were significantly higher in 57 patients with Okuda-Stage I disease, compared to 34 patients with Okuda-Stage II and III disease (73%, 31% and 8% vs. 23%, 6% and 4% p < 0.0001). CONCLUSIONS: Tumor type, tumor size and grade of liver cirrhosis have an independent impact on prognosis of patients with HCC treated by TACE. An appropriate selection of patients is necessary to improve patients survival.
Subject(s)
Antibiotics, Antineoplastic/administration & dosage , Antineoplastic Agents/administration & dosage , Carcinoma, Hepatocellular/therapy , Chemoembolization, Therapeutic , Epirubicin/administration & dosage , Ethiodized Oil/administration & dosage , Liver Neoplasms/therapy , Adult , Aged , Angiography , Carcinoma, Hepatocellular/diagnostic imaging , Carcinoma, Hepatocellular/mortality , Chi-Square Distribution , Female , Humans , Liver Cirrhosis/complications , Liver Neoplasms/diagnostic imaging , Liver Neoplasms/mortality , Male , Meta-Analysis as Topic , Middle Aged , Multivariate Analysis , Patient Selection , Prognosis , Prospective Studies , Regression Analysis , Survival Analysis , Time Factors , Tomography, Spiral Computed , Tomography, X-Ray ComputedABSTRACT
PURPOSE: Thrombomodulin (TM), an integral endothelial receptor, is known for its anticoagulant functions. Moreover, there is evidence of growth-modulating effects of this cell surface -protein. The aim of our study was to establish by in vitro transfection a stable cell line of vascular smooth muscle cells with overexpression of TM for further investigations concerning the influence of TM on cellular proliferation and its potential role during the formation of restenosis. METHODS: Aortic smooth muscle cells of the rat were transfected with cDNA of mouse TM or one of its three mutants (M1, M2, M4) by a liposome-mediated technique. The expression of mouse TM mRNA in the selected clones was proven with the help of RT-PCR. Changes of cell proliferation were determined by proliferation kinetics over 24 days. The quantification of the total protein TM was made by Western blots. RESULTS: In 44 of 100 cases the RT-PCR confirmed a successful transfection of mouse-TM. The clones with transfected TM, M1 or M2 showed an inhibited cell growth, whereas M4 demonstrated an increased proliferation compared with controls. The comparison of amounts of total TM with cell growth of individual clones resulted in a negative correlation between proliferation and TM-expression (coefficient of correlation for TM -0.87, for M1 -0.59). CONCLUSIONS: It is possible to reproduce stable cell-lines of vascular smooth muscle cells with overexpression of TM by the presented model of in vitro transfection. Thus, a basis exists for detailed examinations of growth-regulating mechanisms by TM.
Subject(s)
Constriction, Pathologic/prevention & control , Genetic Therapy , Muscle, Smooth, Vascular/cytology , Thrombomodulin/genetics , Transfection , Analysis of Variance , Angioplasty, Balloon , Animals , Aorta/cytology , Blotting, Western , Cell Count , Cell Division , Cell Line , Culture Media , DNA Replication , DNA, Complementary/genetics , Gene Expression , Kinetics , Liposomes , Mice , RNA, Messenger/analysis , Rats , Recurrence , Reverse Transcriptase Polymerase Chain Reaction , Time FactorsABSTRACT
PURPOSE: To evaluate the dose of (188)Re that completely suppresses growth and clonogenic activity of human aortic smooth muscle cells (haSMC) since these cells are mainly responsible for restenosis occurring after PTA. For comparison, growth and clonogenic activity of endothelial cells (EC) were investigated with corresponding doses. MATERIALS AND METHODS: Two days after plating, haSMC and EC were incubated with (188)Re for five days. The doses applied ranged from 4 to 16 Gy. Cell growth was observed for a period of 20 days (EC) or 30 days (haSMC), respectively. Clonogenic activity was monitored over a period of 20 days for both cell lines. RESULTS: Irradiation caused dose-depend-ent inhibition of cell growth and clonogenic activity both in haSMC and in EC. HaSMC growth was completely blocked with 8 Gy, while EC still showed some proliferation even with 16 Gy. The clonal activity of haSMC was also completely blocked with 8 Gy while EC still showed little clonal activity even with 16 Gy. CONCLUSION: Cell growth of both haSMC and EC can be effectively suppressed in a dose-dependent manner. Only haSMC showed a complete growth arrest with 8 Gy while EC were able to proliferate even with 16 Gy. HaSMC colony formation was completely suppressed after application of 8 Gy, while the EC still showed colony formation activity with 16 Gy. (188)Re has some advantageous properties for intravascular irradiation in comparison to other radionuclides making it an interesting radionuclide for stent coating to prevent restenosis.
Subject(s)
Angioplasty, Balloon , Endothelial Cells/radiation effects , Muscle, Smooth, Vascular/cytology , Muscle, Smooth, Vascular/radiation effects , Radioisotopes/pharmacology , Rhenium/pharmacology , Stents , Aorta/radiation effects , Cell Division/radiation effects , Cell Line , Colony-Forming Units Assay , Constriction, Pathologic/prevention & control , Dose-Response Relationship, Radiation , Endothelial Cells/cytology , Humans , Muscle, Smooth, Vascular/growth & development , Radiation Dosage , Recurrence , Time FactorsABSTRACT
PURPOSE: Imaging artifacts in magnetic resonance tomography (MRT) caused by metallic vascular implants (stents) were characterized systematically in dependence on the material and the construction of the implants as well as with respect to different measurement protocols and for different static field strength B (0). METHODS: Twelve stents, different in material (stainless steel, nitinol, Co-alloy) and/or construction, were examined at B (0) = 0.2 T and 1.0 T with two 2D gradient echo (GE) sequences (TE = 4 and 10 ms), one 3D GE sequence and one spin echo (SE) sequence. The stents were put into water with Gd-DTPA contrast agent. The dependence on the orientation was analyzed for the 9 possibilities of an orthogonal alignment of the stent axis, the direction of B (0), the slice, the read out, and the phase encoding direction. Special interest was given to the visibility of the stent lumen at forced rf excitation, as well as to the influence of broken struts on the signal obtained. RESULTS: For the examined stents GE technique showed, due to spin dephasing regions a total signal loss ranging up to 8 mm away from the stent mashes. The value depends on the stent material, the stent orientation in the scanner and grows with voxel size, echo time and B (0). In SE technique dephasing artifacts vanish and wrong spatial encoding gets visible, rf shielding is more pronounced. The visibility of the stent lumen ranges from nearly unperturbed down to a complete signal loss. An improvement is possible using enlarged flip angles. Broken struts can not be imaged significantly. DISCUSSION: The MR representation of metallic stents commercially available at the time, especially of nitionol stents, can be optimized with a suitable adaptation of the imaging parameters. However, a profound improvement can only be expected from new stent material and design.
Subject(s)
Artifacts , Magnetic Resonance Imaging , Stents , Alloys , Contrast Media , Gadolinium DTPA , Humans , Magnetic Resonance Angiography , Magnetic Resonance Imaging/methods , Metals , Stainless Steel , Time Factors , Tomography, X-Ray ComputedABSTRACT
We report the case of a 45-year-old woman with spondylodiscitis at L1/L2, communicating with paravertebral, intravertebral and bilateral psoas abscesses. Percutaneous computed tomography (CT)-guided abscess drainage and an intravenous antibiotic therapy with Imipenem were performed. After removing the drainage at 2 weeks, the patient was discharged at 4 weeks with normalized blood parameters, normal temperature, and without need for analgesics. The underlying bacterium in the case was a very rare gram-negative anaerobic bacterium: Prevotella intermedia.
Subject(s)
Bacteroidaceae Infections/diagnosis , Discitis/microbiology , Lumbar Vertebrae/microbiology , Prevotella intermedia , Abscess/diagnostic imaging , Female , Humans , Middle Aged , Tomography, X-Ray ComputedABSTRACT
OBJECTIVE: To present technique and results of a microvascular denudation of the common femoral artery of the mouse as a model for inducing intimal hyperplasia in interventional radiology. MATERIALS AND METHODS: Under general anesthesia introduced by intraperitoneal injection, 14 B6129F1 hybrid mice (7 females and 7 males) at a mean age of 12.1 +/- 1.8 weeks and a mean weight of 28 +/- 2.8 grams had a groin incision of the vascular bundle directly distal to the inguinal ligament in preparation of placing a vascular clamp. Thereafter, the femoral artery was dissected distal to the origin of the epigastric artery and a loop prepared for a ligation proximal to the planned arteriotomy. Through an arteriotomy performed free-hand with a pair of micro scissors, a 0.010" (= 0.25 mm) guidewire was introduced into the vessel and advanced to the aortic bifurcation. The guide-wire was moved back and forth three times. The same procedure was performed on the other side as sham-operation, i.e., without introduction and passage of a guidewire. The resulting changes of the vessel wall were evaluated by histology and morphometry. RESULTS: Four weeks after intervention, the mean intima-to-media-ratio (IMR) was 1.80 +/- 0.28. A significant difference was observed between the sexes, with an IMR of 1.41 +/- 0.29 in females and an IMR of 2.24 +/- 0.45 in males (p = 0.0173). The neointima led to an overall luminal loss of 50.2% +/- 8.3% without significant sex difference (p = 0.09), but the average luminal loss was still more severe in females, amounting to 43.9% in comparison to 56.1% in males. This technique induces a significant neointima formation in a reproducible manner. The internal elastic membrane was preserved in all vessels. CONCLUSION: This technique is an excellent model to examine the differences between genetically modified mice to clarify the role of putative key molecules in the pathophysiology of restenosis.
Subject(s)
Angioplasty, Balloon , Arterial Occlusive Diseases/diagnostic imaging , Disease Models, Animal , Femoral Artery/diagnostic imaging , Microsurgery , Stents , Animals , Arterial Occlusive Diseases/pathology , Crosses, Genetic , Female , Femoral Artery/pathology , Femoral Artery/surgery , Hybridization, Genetic , Male , Mice , Mice, Inbred Strains/genetics , Radiography , RecurrenceABSTRACT
PURPOSE: To compare the effectiveness of pulsed (impedance control mode) and non-pulsed (manual control mode) radiofrequency ablation (RFA) by using an internal cooled-clustered electrode. MATERIALS AND METHODS: Ex vivo RF ablations (n = 93) were performed with a 200 W RF generator (Model-Cooled Tip, Radionics, USA) in 10 bovine livers, using the impedance and manual control mode. In the impedance control mode, the generator automatically adjusted the applied RF power to the tissue impedance measured during RF ablation. In the manual control mode, the application of the RF power was constant. Both applications were investigated in a capacity range between 5 and 200 W. The duration for each RF ablation was between 2 and 60 minutes. After RF ablation, the short axis diameter of the necrosis was determined macroscopically and the peripheral zone of the necrosis histologically. RESULTS: The impedance control mode produced lesions with short axis diameters of 5.3 +/- 0.3 cm at a power of 200 W after 60 minutes of RF ablation and the manual control mode lesions with short axis diameters of 4.1 +/- 0.4 cm at a power of 70 W after 8 +/- 2 minutes of RF ablation. The impedance control mode increased significantly the time of RF ablation with higher power and the size of necrosis (p < 0.01). CONCLUSION: In comparison to non-pulsed RF ablation, pulsed RF ablation with internal cooled-clustered electrodes significantly increases the size of the lesions and represents a methodical optimization in our opinion.